Rapport Therapeutics, Inc.: director Wendy B. Young bought 3,789 shares

What happened Wendy B. Young, a director of Rapport Therapeutics, Inc., bought 3,789 shares in an open market or private purchase on Oct 22, 2026. The Form 4 reports a purchase price of $26.39 per share for a total of $99,992.

Key details

• Transaction date and price: Oct 22, 2026 — 3,789 shares at $26.39 per share.
• Total value reported: $99,992.
• Transaction code: P (purchase); described as open market or private purchase on the Form 4.
• Shares owned after the transaction: not reported in the provided filing summary.
• Footnotes or plans: none reported on the Form 4.
• Filing timeliness: Form 4 filed on Oct 22, 2026 (not marked late).

Why it may matter

• The filing reports a straight purchase (code P), not an option exercise, award, gift, or tax withholding.
• This filing does not show why the insider traded or why the company acted.